Basis Clinically Proven NAD+ Supplement for Healthy Aging

Invest in your long-term health with a supplement at the frontier of aging science. Basis by Elysium Health is a revolutionary, clinically proven NAD+ supplement developed by world-renowned MIT scientist Dr. Leonard Guarente. Designed to target aging at its source—the cell—Basis is proven to increase NAD+ levels by an average of 40%, supporting cellular energy, repair, and your body’s ability to age well.*

The Science of NAD+: The Fuel for Your 37.2 Trillion Cells

NAD+ (Nicotinamide Adenine Dinucleotide) is a vital coenzyme found in every cell, essential for creating cellular energy (ATP) and activating the sirtuins that regulate cellular health. As we age, our NAD+ levels can decline by over 50%. Basis provides the essential precursor your body needs, Nicotinamide Riboside (NR-E), to efficiently support the natural production of this critical molecule.*

A Powerful, Synergistic Combination

Basis is formulated with two powerful, science-backed ingredients:

• Nicotinamide Riboside (NR-E): Our exclusive, patented form of NR is a highly efficient precursor that your cells use to create more NAD+, helping to combat the age-related decline.*
• Pterostilbene (PT): A powerful polyphenol similar to resveratrol, PT provides potent antioxidant support and works synergistically with NR-E to support healthy cellular aging.

How to Use for Long-Term Cellular Health

For adults, take two (2) capsules every morning, with or without food. Daily, consistent use is key to sustaining elevated NAD+ levels and achieving the long-term benefits for cellular health.

Important Safety Information

This supplement is intended for healthy adults. Consult your healthcare provider before use if you are pregnant, nursing, have a medical condition, or are taking any medications. Keep out of reach of children.

*Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. The 40% increase in NAD+ levels was demonstrated in a clinical trial of Basis.